NCT07480902 2026-03-18
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Phase NA Recruiting
Clinical Trials
11 trialsNCT07211204 2026-03-03
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
Phase NA Withdrawn
NCT00513526 2023-11-14
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
AIDS Malignancy Consortium
Phase 2 Completed
NCT03404310 2023-09-22
Zinc Sulfate for Human Papillomavirus (HPV)
Corewell Health West
Phase NA Terminated
NCT00873288 2023-03-21
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
Phase NA Completed
NCT01550783 2020-07-31
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
University of Washington
Phase NA Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT00653146 2016-12-05
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Fox Chase Cancer Center
Phase NA Completed
NCT00312286 2016-09-23
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT00703196 2015-10-08
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00091130 2013-06-03
SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
National Cancer Institute (NCI)
Phase 2 Completed